A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer
Public ClinicalTrials.gov record NCT03471663. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I, Open-Label Study of D-0502 Single Agent and D-0502 in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer
Study identification
- NCT ID
- NCT03471663
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- InventisBio Co., Ltd
- Industry
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- D-0502 Drug
- palbociclib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 17, 2018
- Primary completion
- Oct 17, 2023
- Completion
- Oct 17, 2023
- Last update posted
- Jan 7, 2024
2018 – 2023
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Fresno | California | 93720 | — |
| Local Institution | Aurora | Colorado | 80012 | — |
| Local Institution | New Haven | Connecticut | 06511 | — |
| Local Institution | Boston | Massachusetts | 02114 | — |
| Local Institution | Eugene | Oregon | 97401 | — |
| Local Institution | Greenville | South Carolina | 29605 | — |
| Local Institution | Nashville | Tennessee | 37203-1619 | — |
| Local Institution | Dallas | Texas | 75246 | — |
| Local Institution | San Antonio | Texas | 78217 | — |
| Local Institution | San Antonio | Texas | 78229 | — |
| Local Institution | Tyler | Texas | 75702 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03471663, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03471663 live on ClinicalTrials.gov.